Discontinuing bDMARD treatment before orthopedic surgery may increase the risk for postoperative disease flares among patients with RA.

Patients who require biologic disease-modifying antirheumatic drugs (DMARDs) for severe RA are less likely to achieve sustained DMARD-free remission than those not needing the medication. Patients ...

For a long time, treatments for autoimmune diseases could only quash the symptoms - now new drugs may tackle the underlying ...

The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone ...

Deodhar A, Helliwell P, Boencke W-H, et al. Guselkumab, an anti-interleukin-23p19 monoclonal antibody, in patients with active psoriatic arthritis who were biologic-naïve or prior TNFα ...

If your joints are extra achy at this time of year, you're in good company. Wintery and wet weather can trigger flare-ups for ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Biologic agents have been used to treat rheumatoid arthritis (RA) for more than a decade. Their use has dramatically expanded the therapeutic options, leading to unprecedented clinical, structural and ...

The US Food and Drug Administration (FDA) has approved more than 23,000 prescription drugs, with many more in development. Increasingly, therapeutic manufacturers are discovering that the key to ...